• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, September 21, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

McMaster University researchers pinpoint potential treatment for lethal childhood cancer

Bioengineer by Bioengineer
November 10, 2022
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

                                                                                                     Media Release

Sheila Singh and William Gwynne

Credit: McMaster University

                                                                                                     Media Release

 

Embargoed by Cancer Cell until

Thursday, Nov. 10, 2022, at 11 a.m. ET

 

Hamilton, ON (Nov. 10, 2022) – An enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster University-led study.

 

Researchers discovered that by blocking the production of an enzyme called DHODH, they were able to halt the growth of MYC gene-amplified medulloblastoma in mouse models, the most aggressive subtype of this cancer.

 

First author William Gwynne said that while blocking DHODH stops the cancer spreading, healthy brain and nerve cells are spared. This will avoid the after-effects of current treatments, including radiotherapy and chemotherapy, which can impair children’s brain development even if their cancer is successfully treated.

 

“This potential treatment pathway will allow us to kill the weeds but save the flower of the developing brain,” said Gwynne, a post-doctoral researcher of the Centre for Discovery in Cancer Research

 

“This DHODH treatment target is full of promise, but it will take several years before we can reach the clinical trial stage. This potential new treatment, unlike current ones, will not be toxic to the developing brain.”

 

The study was published in the journal Cancer Cell on Nov. 10.

 

Gwynne said all types of medulloblastoma originate from neural stem cells in the cerebellum, the part of the brain that controls voluntary actions such as walking, balance, co-ordination and speech. The cerebellum develops fully after a child is born.

 

He said the cancer starts when cell development in the cerebellum goes awry but studying the causes of this dysfunction can lead to new treatments.

 

Common medulloblastoma symptoms include gait and balance difficulties, nausea, headaches and swelling of the head.

 

By the time children are diagnosed, the cancer has often spread throughout the brain and into their spinal fluid, especially if it is the MYC-amplified subtype.

 

Gwynne said that medulloblastoma is the most common pediatric brain cancer diagnosed in children and brain tumors have recently overtaken leukemia as the most lethal childhood malignancy.

 

“Over the last two decades, we have made significant treatment advances in surgery, chemotherapy and radiotherapy, so the five-year survival rate for medulloblastoma is now more than 70 per cent,” said Gwynne.

 

“However, the roughly 30 per cent of children whose cancer does not respond to currently available treatments have no other options.”

 

External funding for the study was provided by the Canadian Institutes of Health Research, the Ontario Institute for Cancer Research Cancer Stem Cell Program, the Canadian Cancer Society Research Institute, the Box Run Foundation and the Team Kelsey Foundation.

 

-30-

 

Editors:

Pictures of Sheila Singh and William Gwynne may be found at https://bit.ly/3fPBYc6.

 

 

For information, please contact:

Veronica McGuire

Media Relations

Faculty of Health Sciences

McMaster University

289-776-6952

[email protected]

 

 



Journal

Cancer Cell

DOI

10.1016/j.ccell.2022.10.009

Method of Research

Experimental study

Subject of Research

Animals

Article Title

Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma

Article Publication Date

10-Nov-2022

COI Statement

none to declare

Share12Tweet8Share2ShareShareShare2

Related Posts

Glen Barber, PhD

Sylvester researcher earns prestigious Columbia University award

September 21, 2023
62-year-old with serum PSA level of 4.11 ng/mL. Prostate MRI shows lesion in left mid anterior transition zone.

Prostate cancer upgrade, downgrade rates in PI-RADS 2.0 versus 2.1

September 21, 2023

Lower risk of haematological cancer after bariatric surgery

September 21, 2023

St. Jude refines definition and hones treatment of hyperdiploid leukemia

September 20, 2023

POPULAR NEWS

  • blank

    Microbe Computers

    58 shares
    Share 23 Tweet 15
  • University of South Florida scientist: Barnacles may help reveal location of lost Malaysia Airlines flight MH370

    46 shares
    Share 18 Tweet 12
  • Lithuanian invention at the forefront of solar technology breakthrough

    41 shares
    Share 16 Tweet 10
  • A pioneering study from Politecnico di Milano sheds light on one of the still poorly understood aspects of cancer

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

SBQuantum to test quantum magnetometer in space – designed to map Earth’s magnetic field

UW team’s shape-changing smart speaker lets users mute different areas of a room

New study finds that sewage release is worse for rivers than agriculture

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 57 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In